We’re proud to announce that Leigh Tyrer has joined KAI Conversations as a Board Advisor.
Leigh brings over 20 years of experience leading #digitaltransformation across the
#pharmaceutical sector. During his 18-year tenure at MSD, he held global leadership roles spanning digital marketing, multichannel strategy, and customer engagement, driving enterprise-level change and advancing digital excellence worldwide.
Now, as Managing Owner of CX Consulting Services and former Principal Consultant at DT Associates, Leigh advises top pharmaceutical firms on achieving CX and digital maturity. His work cuts across capability benchmarking, commercial excellence, and innovation. Aligning seamlessly with KAI’s mission to transform how life science companies engage with healthcare professionals.
Leigh’s expertise in pharmaceutical sales, CRM, cross-functional leadership, and digital strategy will be instrumental in shaping KAI’s product roadmap and partnership model as we scale across the US and Europe.
Leigh commented on his appointment, “There has been an explosion of AI initiatives within the industry over the last couple of years with many failing to deliver meaningful business impact, sustainability or the ability to scale across the organisation. Couple this with the level of investment in field teams and the less than desirable sentiment from customers, it's time to take stock and implement a real change.
KAI conversations is an industry leading AI solution helping many pharma companies develop field teams and transform how they engage with their customers. KAI delivers on-going personalized development plans, improves coaching and relationships with line managers, provides actionable customer insights across the organisation and most importantly improves customer relationships.
I'm excited to join KAI's board and partner with their outstanding team, I truly believe this capability will support the transformation needed to take customer engagement to the next level.”
CEO of KAI Conversations, David Williams commented on Leigh's appointment, “Clients trust Leigh because of his deep pharma client side experience. It's rare to find someone that combines deep AI, capability building and engagement expertise. We're delighted to have Leigh as part of the team to help clients get the most from our leading Life Sciences Conversation Intelligence Platform.”
His appointment signals our continued investment in building a best-in-class advisory team to help pharma teams turn conversations into confident action.
Welcome to the team, Leigh.
